← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

NDA · New Drug Application · Sponsor: SAGENT PHARMS INC · Approved 2017-09-12

Drug application

FDA Application #

NDA208385

Application type

New Drug Application

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2017-09-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown